Medicare Part D Coverage of Drugs Selected for the Drug Price Negotiation Program.
JAMA Health Forum
; 5(2): e235237, 2024 Feb 02.
Article
em En
| MEDLINE
| ID: mdl-38334994
This cross-sectional study describes and historically benchmarks Medicare Part D coverage in 2019 and 2023 for the first 10 drugs selected for negotiation.
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Medicare Part D
/
Medicamentos sob Prescrição
Idioma:
En
Ano de publicação:
2024
Tipo de documento:
Article